Hao Tian International Construction Explores Purchase of Stake in Zero-Emission Automaker

Hao Tian International Construction Investment Group (HKG:1341) is considering acquiring a 49% stake in Target Company, a joint July 5 filing by the company and its substantial shareholder Aceso Life

MT NewswiresJul 8 06:06 ET

Hao Tian Intl (01341.HK) and Aceso Life Sci (00474.HK): Hao Tian Intl Construction and Investment intends to acquire approximately 49.42% of the shares of Wisdom Group Holdings.

On July 5th, GTI News reported that Hao Tian Intl (01341.HK) and Aceso Life Sci (00474.HK) issued an announcement that Aceso Life Sci and Hao Tian Intl Investment joyfully announced that Hao Tian Intl Investment has signed a non-legally binding letter of intent with the target company (as defined below), based on which Hao Tian Intl Investment has expressed its intention to acquire, while a major shareholder of the target company expressed his intention to sell and encourage others to sell, and Wisdom Group Holdings Limited (the "Target Company") has approximately 49.42% of the total issued share capital.

Gelonghui FinanceJul 5 06:50 ET

Express News | Hao Tian International Construction Investment- Deal to Be Satisfied 50% by Cash & 50% by Issuance of Shares of Co at Issue Price of HK$0.7 per Share

ReutersJul 5 06:47 ET

Aceso Life Science Logs Higher Losses in Fiscal Year 2024

Aceso Life Science Group (HKG:0474) reported a loss attributable to the owners of HK$462 million for the fiscal year ended March 31, compared with a loss of HK$264 million in the previous year, accord

MT NewswiresJun 26 22:42 ET

Aceso Life Sci (00474.HK): Annual equity holders of the company hold a loss of HKD 462 million.

On June 27th, Gralonhui reports that Aceso Life Sci (00474.HK) has announced that it achieved revenue of HKD 228 million for the fiscal year ending March 31, 2024, a 26.92% year-on-year decrease; Gross profit of HKD 117 million, down 17.02% YoY; Net loss attributable to shareholders of the company was HKD 462 million for the year, compared with HKD 264 million for the same period last year; Basic loss per share was HKD 6.35. The decrease in total revenue in this fiscal year was mainly due to the decrease in sales of construction machinery and spare parts sales and rental income of construction machinery.

Gelonghui FinanceJun 26 19:50 ET

Express News | Corrected-Aceso Life Science Group FY Net Income HKD -809 Million (Corrects Amount)

ReutersJun 26 19:47 ET